NM_005751.5:c.8375A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005751.5(AKAP9):​c.8375A>G​(p.Asn2792Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 1,613,262 control chromosomes in the GnomAD database, including 116,125 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N2792H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.34 ( 9247 hom., cov: 32)
Exomes 𝑓: 0.38 ( 106878 hom. )

Consequence

AKAP9
NM_005751.5 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.334

Publications

63 publications found
Variant links:
Genes affected
AKAP9 (HGNC:379): (A-kinase anchoring protein 9) The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternate splicing of this gene results in at least two isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. These signaling proteins include type II protein kinase A, serine/threonine kinase protein kinase N, protein phosphatase 1, protein phosphatase 2a, protein kinase C-epsilon and phosphodiesterase 4D3. [provided by RefSeq, Aug 2008]
AKAP9 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
  • long QT syndrome 11
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.6543946E-4).
BP6
Variant 7-92083384-A-G is Benign according to our data. Variant chr7-92083384-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136340.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.382 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKAP9NM_005751.5 linkc.8375A>G p.Asn2792Ser missense_variant Exon 33 of 50 ENST00000356239.8 NP_005742.4 Q99996-2Q6PJH3Q5GIA7
AKAP9NM_147185.3 linkc.8351A>G p.Asn2784Ser missense_variant Exon 33 of 50 NP_671714.1 Q99996-3Q6PJH3Q5GIA7
AKAP9NM_001379277.1 linkc.3020A>G p.Asn1007Ser missense_variant Exon 12 of 29 NP_001366206.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKAP9ENST00000356239.8 linkc.8375A>G p.Asn2792Ser missense_variant Exon 33 of 50 1 NM_005751.5 ENSP00000348573.3 Q99996-2

Frequencies

GnomAD3 genomes
AF:
0.340
AC:
51609
AN:
151960
Hom.:
9249
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.252
Gnomad AMI
AF:
0.233
Gnomad AMR
AF:
0.338
Gnomad ASJ
AF:
0.543
Gnomad EAS
AF:
0.172
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.386
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.386
Gnomad OTH
AF:
0.369
GnomAD2 exomes
AF:
0.359
AC:
89641
AN:
249908
AF XY:
0.366
show subpopulations
Gnomad AFR exome
AF:
0.249
Gnomad AMR exome
AF:
0.298
Gnomad ASJ exome
AF:
0.546
Gnomad EAS exome
AF:
0.171
Gnomad FIN exome
AF:
0.392
Gnomad NFE exome
AF:
0.390
Gnomad OTH exome
AF:
0.383
GnomAD4 exome
AF:
0.379
AC:
553710
AN:
1461184
Hom.:
106878
Cov.:
42
AF XY:
0.380
AC XY:
276338
AN XY:
726924
show subpopulations
African (AFR)
AF:
0.248
AC:
8294
AN:
33464
American (AMR)
AF:
0.301
AC:
13476
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.541
AC:
14132
AN:
26132
East Asian (EAS)
AF:
0.185
AC:
7330
AN:
39672
South Asian (SAS)
AF:
0.389
AC:
33550
AN:
86250
European-Finnish (FIN)
AF:
0.387
AC:
20608
AN:
53286
Middle Eastern (MID)
AF:
0.418
AC:
2412
AN:
5768
European-Non Finnish (NFE)
AF:
0.388
AC:
431254
AN:
1111520
Other (OTH)
AF:
0.375
AC:
22654
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
18668
37337
56005
74674
93342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13428
26856
40284
53712
67140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.339
AC:
51620
AN:
152078
Hom.:
9247
Cov.:
32
AF XY:
0.339
AC XY:
25231
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.251
AC:
10423
AN:
41478
American (AMR)
AF:
0.338
AC:
5161
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.543
AC:
1884
AN:
3472
East Asian (EAS)
AF:
0.173
AC:
892
AN:
5166
South Asian (SAS)
AF:
0.385
AC:
1858
AN:
4820
European-Finnish (FIN)
AF:
0.386
AC:
4077
AN:
10566
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.386
AC:
26222
AN:
67980
Other (OTH)
AF:
0.368
AC:
776
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1717
3434
5151
6868
8585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.373
Hom.:
28077
Bravo
AF:
0.331
TwinsUK
AF:
0.377
AC:
1397
ALSPAC
AF:
0.392
AC:
1511
ESP6500AA
AF:
0.268
AC:
1180
ESP6500EA
AF:
0.401
AC:
3451
ExAC
AF:
0.359
AC:
43538
Asia WGS
AF:
0.294
AC:
1026
AN:
3478
EpiCase
AF:
0.392
EpiControl
AF:
0.402

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Aug 11, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 08, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Long QT syndrome 11 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital long QT syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 18, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
7.0
DANN
Benign
0.81
DEOGEN2
Benign
0.27
.;T;T;.
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.77
T;T;T;T
MetaRNN
Benign
0.00057
T;T;T;T
MetaSVM
Benign
-0.92
T
PhyloP100
0.33
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-2.0
N;.;.;N
REVEL
Benign
0.070
Sift
Benign
0.23
T;.;.;T
Sift4G
Benign
0.87
.;T;.;T
Vest4
0.061
MPC
0.046
ClinPred
0.0056
T
GERP RS
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.016
gMVP
0.078
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6960867; hg19: chr7-91712698; COSMIC: COSV62339152; COSMIC: COSV62339152; API